1: Gargett CE, Wiley JS. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br J Pharmacol. 1997 Apr;120(8):1483-90. doi: 10.1038/sj.bjp.0701081. PMID: 9113369; PMCID: PMC1564633.
2: Brozinick JT Jr, Reynolds TH, Dean D, Cartee G, Cushman SW. 1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle. Biochem J. 1999 May 1;339 ( Pt 3)(Pt 3):533-40. PMID: 10215590; PMCID: PMC1220187.
3: Okazaki K, Ishikawa T, Inui M, Tada M, Goshima K, Okamoto T, Hidaka H. KN-62, a specific Ca++/calmodulin-dependent protein kinase inhibitor, reversibly depresses the rate of beating of cultured fetal mouse cardiac myocytes. J Pharmacol Exp Ther. 1994 Sep;270(3):1319-24. PMID: 7932185.
4: Cui ZJ, Hidaka H, Dannies PS. KN-62, a calcium/calmodulin-dependent protein kinase II inhibitor, inhibits high potassium-stimulated prolactin secretion and intracellular calcium increases in anterior pituitary cells. Biochim Biophys Acta. 1996 Feb 29;1310(3):343-7. doi: 10.1016/0167-4889(95)00170-0. PMID: 8599613.
5: Gunosewoyo H, Coster MJ, Kassiou M. Molecular probes for P2X7 receptor studies. Curr Med Chem. 2007;14(14):1505-23. doi: 10.2174/092986707780831023. PMID: 17584060.
6: Maurer JA, Wenger BW, McKay DB. Effects of protein kinase inhibitors on morphology and function of cultured bovine adrenal chromaffin cells: KN-62 inhibits secretory function by blocking stimulated Ca2+ entry. J Neurochem. 1996 Jan;66(1):105-13. doi: 10.1046/j.1471-4159.1996.66010105.x. PMID: 8522941.
7: Tsutsui M, Yanagihara N, Fukunaga K, Minami K, Nakashima Y, Kuroiwa A, Miyamoto E, Izumi F. Ca(2+)/calmodulin-dependent protein kinase II inhibitor KN-62 inhibits adrenal medullary chromaffin cell functions independent of its action on the kinase. J Neurochem. 1996 Jun;66(6):2517-22. doi: 10.1046/j.1471-4159.1996.66062517.x. PMID: 8632177.
8: Ishikawa N, Hashiba Y, Hidaka H. Effect of a new Ca2(+)-calmodulin-dependent protein kinase II inhibitor on GABA release in cerebrospinal fluid of the rat. J Pharmacol Exp Ther. 1990 Aug;254(2):598-602. PMID: 2384887.
9: Inagaki N, Suzuki S, Kitai H, Nakatogawa N, Kuji N, Iwahashi K, Yoshimura Y. Effect of KN-62, a selective inhibitor of calmodulin-dependent kinase II, on mouse oocyte activation. J Assist Reprod Genet. 1997 Nov;14(10):609-16. doi: 10.1023/a:1022541020458. PMID: 9447464; PMCID: PMC3454741.
10: Wenham RM, Landt M, Walters SM, Hidaka H, Easom RA. Inhibition of insulin secretion by KN-62, a specific inhibitor of the multifunctional Ca2+/calmodulin- dependent protein kinase II. Biochem Biophys Res Commun. 1992 Nov 30;189(1):128-33. doi: 10.1016/0006-291x(92)91534-w. PMID: 1333187.
11: Humphreys BD, Virginio C, Surprenant A, Rice J, Dubyak GR. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol Pharmacol. 1998 Jul;54(1):22-32. doi: 10.1124/mol.54.1.22. PMID: 9658186.
12: Fan GH, Wang LZ, Qiu HC, Ma L, Pei G. Inhibition of calcium/calmodulin- dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol Pharmacol. 1999 Jul;56(1):39-45. doi: 10.1124/mol.56.1.39. PMID: 10385682.
13: Nishijima KA, Wall MM, Siderhurst MS. Demonstrating Pathogenicity of Enterobacter cloacae on Macadamia and Identifying Associated Volatiles of Gray Kernel of Macadamia in Hawaii. Plant Dis. 2007 Oct;91(10):1221-1228. doi: 10.1094/PDIS-91-10-1221. PMID: 30780515.
14: Wang X, Yu G, Hou X, Zhou J, Yang B, Zhang L. Rebound bursts in GABAergic neurons of the thalamic reticular nucleus in postnatal mice. Physiol Res. 2010;59(2):273-80. Epub 2009 Jun 19. PMID: 19537935.
15: Kubota M, Narita K, Murayama T, Suzuki S, Soga S, Usukura J, Ogawa Y, Kuba K. Type-3 ryanodine receptor involved in Ca2+-induced Ca2+ release and transmitter exocytosis at frog motor nerve terminals. Cell Calcium. 2005 Dec;38(6):557-67. doi: 10.1016/j.ceca.2005.07.008. Epub 2005 Sep 12. PMID: 16157373.
16: Chang MC, Khanna R, Schlichter LC. Regulation of Kv1.3 channels in activated human T lymphocytes by Ca(2+)-dependent pathways. Cell Physiol Biochem. 2001;11(3):123-34. doi: 10.1159/000047800. PMID: 11410708.
17: Noronha KF, Mercier AJ. A role for calcium/calmodulin-dependent protein kinase in mediating synaptic modulation by a neuropeptide. Brain Res. 1995 Feb 27;673(1):70-4. doi: 10.1016/0006-8993(94)01396-y. PMID: 7757481.
18: Ridley DL, Rogers A, Wonnacott S. Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells. Br J Pharmacol. 2001 Aug;133(8):1286-95. doi: 10.1038/sj.bjp.0704207. PMID: 11498514; PMCID: PMC1621156.
19: Satoh R, Nakabayashi Y, Kano M. Ca2+/calmodulin-dependent regulation of the density of Na+ channels in embryonic chick skeletal muscle cells during their development in culture. Biochem Biophys Res Commun. 1994 Sep 15;203(2):852-6. doi: 10.1006/bbrc.1994.2261. PMID: 8093067.
20: Hishinuma S, Ogura K. Ca(2+)/calmodulin-mediated regulation of the desensitizing process in G(q) protein-coupled histamine H(1) receptor-mediated Ca(2+) responses in human U373 MG astrocytoma cells. J Neurochem. 2000 Aug;75(2):772-81. doi: 10.1046/j.1471-4159.2000.0750772.x. PMID: 10899954.